ATX 8.96% 6.1¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-9

  1. 1,840 Posts.
    lightbulb Created with Sketch. 33
    Was MPACT commercialised? Didn’t seem to offer a major improvement - although getting any survivors beyond months and into years is a positive but the population responder improvement seems quite material for AMP945 at this early stage. They may raise ahead of q3 and see if there’s lift off so they have hedged cash needs.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
-0.006(8.96%)
Mkt cap ! $16.56M
Open High Low Value Volume
6.5¢ 6.5¢ 5.6¢ $42.68K 709.9K

Buyers (Bids)

No. Vol. Price($)
1 642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 236421 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.